The global Blood Screening Market is anticipated to achieve a CAGR of 8.2% during the forecast period, with the market size expected to reach nearly US$ 4.69 billion by 2029.
Report Scope:
The comprehensive report includes a detailed analysis of the impact of the COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. As lockdown measures varied across regions and countries, the report assesses the diverse effects on different market segments and regions. Providing insights into the short-term and long-term impact on the market, this report equips decision-makers with valuable information for devising strategies to navigate both immediate and future challenges by region.
Click To get FREE SAMPLE PDF (Including Full TOC, Table Figures) : https://www.maximizemarketresearch.com/request-sample/13686
Research Methodology:
To obtain accurate and reliable data, a robust research methodology was employed, ensuring the report’s credibility and relevance. The research process involved collecting and analyzing data from multiple sources, including primary and secondary sources, industry experts, and market leaders. The gathered data was then thoroughly examined, interpreted, and presented in a clear and concise manner, providing actionable insights.
Drivers and Restraints:
The blood screening market is poised for significant growth due to factors such as the increase in the prevalence of infectious diseases, rising healthcare awareness, a surge in blood donations, and the adoption of nucleic acid amplification tests (NAT). These drivers are expected to create lucrative opportunities and propel market growth. However, challenges such as competition from substitute techniques, low blood donation rates in comparison to demand, and the high cost of screening kits and instruments may impede market growth.
Get full access of report : https://www.maximizemarketresearch.com/market-report/blood-screening-market/13686/
Regional Insights:
The North American market is projected to experience substantial growth during the forecast period, with an expected CAGR of %. This growth is attributed to the region’s growing adoption of nucleic acid tests (NAT) and increased involvement of various government associations in blood donation, screening, and transfusion activities. Meanwhile, the Asia-Pacific (APAC) region is also set to grow at a % CAGR during the forecast period, driven by the high adoption rate of technologically advanced devices and ongoing improvements in healthcare infrastructure.
Key Players:
• Abbott Laboratories
• Grifols
• Roche Diagnostics
• Thermo Fisher Scientific, Inc.
• bioMérieux
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Ortho Clinical Diagnostics, Inc.
• Becton, Dickinson, and Company
• Beckman Coulter, Inc.
• Becton Dickinson and Company
• Grifols
• Danaher Corporation (Beckman Coulter)
• F. Hoffmann-La Roche Ltd.
• Enzo Biochem Inc.
• Meridian Bioscience, Inc.
• BD
• Cepheid
• Immucor, Inc.
• Hologic Inc
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
